FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet ...

President Trump has threatened to slap a 200% tariff on foreign-made pharmaceuticals. That would roil the $200 billion-plus ...

Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

President Trump on Tuesday threatened to impose up to 200 percent tariffs on pharmaceutical products imported into the U.S. “very soon.” “If they have to bring the pharmaceuticals into the ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...